La patentabilidad de la medicina tradicional palenquera: antídoto jurídico para el TLC con estados unidos
This article presents a legal analysis of how the signing of the Trade Promotion Agreement between Colombia and the United States, which runs from May 15, 2012, risking the traditional medicine of San Basilio de Palenque. In his tenor it argues that the agreement violates existing guarantees for tra...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo |
| Idioma: | Castellano |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://dialnet.unirioja.es/servlet/oaiart?codigo=8014554 |
| Fuente: | Revista Jurídica Mario Alario D'Filippo, ISSN 2256-2796, Vol. 6, Nº. 12, 2014, pags. 71-86 |
| Etiquetas: |
Añadir etiqueta
Sin etiquetas: Sea el primero en etiquetar este registro
|
| Sumario: |
This article presents a legal analysis of how the signing of the Trade Promotion Agreement between Colombia and the United States, which runs from May 15, 2012, risking the traditional medicine of San Basilio de Palenque. In his tenor it argues that the agreement violates existing guarantees for traditional knowledge, contained in instruments such as the Convention on Biological Diversity, Decisions 391 of 1996 and 486 of 2000 of the Andean Community of Nations, and TRIPS. This opens the door for US pharmaceutical companies patented chemical molecules of plants used in traditional medicine palenquera without equitable economic benefits for this community. |
|---|